Abstract
Introduction: Prostate cancer (PCa) is the most common malignant tumor in men, with acinar adenocarcinoma as the predominant subtype. While PCa metastases typically affect bones, penile metastases are exceedingly rare. Penile tumors are generally squamous cell carcinoma (SCC), with p16 overexpression often used as a surrogate marker for oncogenic human papillomavirus (HPV) infection. Case Presentation: We report the case of an 85-year-old male with a history of PCa (grade group 5) treated with irradiation and hormonal therapy, who presented with a progressive penile lesion initially misdiagnosed as HPV-associated SCC. Immunohistochemistry revealed diffuse panCK, p16, NKX3.1, androgen receptor, and ERG positivity, with Rb1 protein loss confirming metastatic PCa. Prostate-specific antigen levels remained within the normal range, complicating the diagnosis. Conclusion: This case emphasizes the importance of thorough clinicopathological correlation in unusual metastatic presentations and highlights that p16 overexpression, even in penile tumors, may indicate Rb1 inactivation rather than HPV-related SCC.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Sung
H
, Ferlay
J
, Siegel
RL
, Laversanne
M
, Soerjomataram
I
, Jemal
A
, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
. CA Cancer J Clin
. 2021
;71
(3
):209
–49
. 2.
Ahmed
HU
, El-Shater Bosaily
A
, Brown
LC
, Gabe
R
, Kaplan
R
, Parmar
MK
, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
. Lancet
. 2017
;389
(10071
):815
–22
. 3.
Gandaglia
G
, Abdollah
F
, Schiffmann
J
, Trudeau
V
, Shariat
SF
, Kim
SP
, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis
. Prostate
. 2014
;74
(2
):210
–6
. 4.
Canete-Portillo
S
, Sanchez
DF
, Cubilla
AL
. Pathology of invasive and intraepithelial penile neoplasia
. Eur Urol Focus
. 2019
;5
(5
):713
–7
. 5.
Doorbar
J
. Molecular biology of human papillomavirus infection and cervical cancer
. Clin Sci
. 2006
;110
(5
):525
–41
. 6.
Di Fiore
R
, D’Anneo
A
, Tesoriere
G
, Vento
R
. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
. J Cell Physiol
. 2013
;228
(8
):1676
–787
. 7.
Mearini
L
, Colella
R
, Zucchi
A
, Nunzi
E
, Porrozzi
C
, Porena
M
. A review of penile metastasis
. Oncol Rev
. 2012
;6
(1
):e10
. 8.
Fujita
N
, Kurokawa
R
, Kaneshima
R
, Machida
M
, Kawai
G
, Wada
T
, et al. Patient with penile metastasis from prostate cancer and survival over 5 years: a case report with longitudinal evaluation using computed tomography and magnetic resonance imaging
. Radiol Case Rep
. 2021
;16
(6
):1255
–8
. 9.
Combes
AD
, Palma
CA
, Calopedos
R
, Wen
L
, Woo
H
, Fulham
M
, et al. PSMA PET-CT in the diagnosis and staging of prostate cancer
. Diagnostics
. 2022
;12
(11
):2594
. 10.
Epstein
JI
, Egevad
L
, Humphrey
PA
, Montironi
R
; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group
. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference
. Am J Surg Pathol
. 2014
;38
(8
):e6
–19
. 11.
Gurel
B
, Ali
TZ
, Montgomery
EA
, Begum
S
, Hicks
J
, Goggins
M
, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors
. Am J Surg Pathol
. 2010
;34
(8
):1097
–105
. 12.
Leibovici
D
, Spiess
PE
, Agarwal
PK
, Tu
SM
, Pettaway
CA
, Hitzhusen
K
, et al. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level
. Cancer
. 2007
;109
(2
):198
–204
. 13.
Formaggio
N
, Rubin
MA
, Theurillat
JP
. Loss and revival of androgen receptor signaling in advanced prostate cancer
. Oncogene
. 2021
;40
(7
):1205
–216
. 14.
Faisal
FA
, Lotan
TL
. The genomic and molecular pathology of prostate cancer: clinical implications for diagnosis, prognosis, and therapy
. Adv Anat Pathol
. 2020
;27
(1
):11
–9
. 15.
Tan
HL
, Haffner
MC
, Esopi
DM
, Vaghasia
AM
, Giannico
GA
, Ross
HM
, et al. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas
. Mod Pathol
. 2015
;28
(3
):446
–56
. 16.
Han
W
, Liu
M
, Han
D
, Li
M
, Toure
AA
, Wang
Z
, et al. RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
. Oncogene
. 2022
;41
(6
):852
–64
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
